{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:42:33Z","timestamp":1773679353187,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":49,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007168.pub2","type":"reference-entry","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T17:22:47Z","timestamp":1233681767000},"source":"Crossref","is-referenced-by-count":22,"title":["Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis"],"prefix":"10.1002","author":[{"given":"Edward F","family":"Nash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Ratjen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Tullis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD007168.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1378\/chest.127.1.308","article-title":"A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis","volume":"127","author":"Bishop","year":"2005","journal-title":"Chest"},{"key":"10.1002\/14651858.CD007168.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/030006059502300409","article-title":"The management of cystic fibrosis with carbocysteine lysine salt: single-blind comparative study with ambroxol hydrochloride","volume":"23","author":"Caramia","year":"1995","journal-title":"The Journal of International Medical Research"},{"issue":"2","key":"10.1002\/14651858.CD007168.pub2-BIB3|cit3","first-page":"82","article-title":"A double-blind study of the use of acetylcysteine in patients with cystic fibrosis","volume":"32","author":"Howatt","year":"1966","journal-title":"University of Michigan Medical Center Journal"},{"issue":"1","key":"10.1002\/14651858.CD007168.pub2-BIB4|cit4","first-page":"40","article-title":"Controlled trial of oral N-acetylcysteine in cystic fibrosis","volume":"18","author":"Mitchell","year":"1982","journal-title":"Australian Paediatric Journal"},{"key":"10.1002\/14651858.CD007168.pub2-BIB5|cit5","series-title":"Proceedings of the 9th International Cystic Fibrosis Congress; 1984 June 9-15; Brighton, England","first-page":"3.04","article-title":"A double-blind placebo controlled trial with ambroxol and N-Acetylcysteine for mucolytic treatment in cystic fibrosis [abstract]","author":"Ratjen","year":"1984"},{"issue":"4","key":"10.1002\/14651858.CD007168.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00441781","article-title":"A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis","volume":"144","author":"Ratjen","year":"1985","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD007168.pub2-BIB7|cit7","series-title":"Proceedings of 14th Annual Meeting of the European Working Group for Cystic Fibrosis; 1986 Sept 1-2; Budapest, Hungary","first-page":"129","article-title":"Effect of peroral N-acetylcysteine in patients with cystic fibrosis and primary cilia dyskinesia [abstract]","author":"Stafanger","year":"1986"},{"issue":"2","key":"10.1002\/14651858.CD007168.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1183\/09031936.93.01020161","article-title":"The clinical effect and the effect on the ciliary motility of oral N-acetylcysteine in patients with cystic fibrosis and primary ciliary dyskinesia","volume":"1","author":"Stafanger","year":"1988","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD007168.pub2-BIB9|cit9","first-page":"R(c)29","article-title":"The effect of oral Nacteylcysteine on lung function CF patients [abstract]","volume":"74","author":"Stafanger","year":"1988","journal-title":"Excerpta Medica, Asia Pacific Congress Series"},{"issue":"3","key":"10.1002\/14651858.CD007168.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1183\/09031936.93.02030234","article-title":"N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility","volume":"2","author":"Stafanger","year":"1989","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD007168.pub2-BIB11|cit11","series-title":"Proceedings of 9th Meeting European Working Group for Cystic Fibrosis; 1979 June 12-13; Noordwijkerhout, The Netherlands","first-page":"58","article-title":"A controlled trial of intermittent aerosol therapy in patients with cystic fibrosis [abstract]","author":"Weller","year":"1979"},{"issue":"1","key":"10.1002\/14651858.CD007168.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/thx.35.1.42","article-title":"Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis","volume":"35","author":"Weller","year":"1980","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD007168.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1183\/09031936.02.00025802","article-title":"Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis","volume":"19","author":"App","year":"2002","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD007168.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jama.1967.03120010059010","article-title":"Bronchial lavage in cystic fibrosis. A comparison of agents","volume":"199","author":"Cezeaux","year":"1967","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007168.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/(SICI)1099-0496(199609)22:3<161::AID-PPUL4>3.0.CO;2-S","article-title":"Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase","volume":"22","author":"Dasgupta","year":"1996","journal-title":"Pediatric Pulmonology"},{"issue":"1","key":"10.1002\/14651858.CD007168.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1542\/peds.55.1.96","article-title":"Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride)","volume":"55","author":"Dietzsch","year":"1975","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD007168.pub2-BIB17|cit17","first-page":"122","article-title":"Oral acetylcysteine in cystic fibrosis. A co-operative study","volume":"111","author":"Gotz","year":"1980","journal-title":"European Journal of Respiratory Disease. Supplement"},{"issue":"7","key":"10.1002\/14651858.CD007168.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/rccm.200308-1104OC","article-title":"Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis","volume":"169","author":"Griese","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007168.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000195725","article-title":"Immediate effect of various treatments on lung function in infants with cystic fibrosis","volume":"55","author":"Maayan","year":"1989","journal-title":"Respiration"},{"issue":"7","key":"10.1002\/14651858.CD007168.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/ajrccm.165.7.2105032","article-title":"Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis","volume":"165","author":"Snyder","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"9","key":"10.1002\/14651858.CD007168.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/ptj\/56.9.999","article-title":"Bronchial drainage with aerosol medications in cystic fibrosis","volume":"56","author":"Tecklin","year":"1976","journal-title":"Physical Therapy"},{"issue":"Suppl 29","key":"10.1002\/14651858.CD007168.pub2-BIB22|cit22","first-page":"295","article-title":"Phase 2 trial of high-dose oral N-Acetylcysteine as a systemic antioxidant and inhibitor of lung inflammation in CF [abstract]","volume":"41","author":"Tirouvanziam","year":"2006","journal-title":"Pediatric Pulmonology"},{"issue":"5","key":"10.1002\/14651858.CD007168.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/ajrccm\/144.5.1202","article-title":"Lung function testing: selection of reference values and interpretative strategies","volume":"144","year":"1991","journal-title":"American Review of Respiratory Disease"},{"issue":"Suppl","key":"10.1002\/14651858.CD007168.pub2-BIB24|cit24","first-page":"217","article-title":"Toxicological, pharmacokinetic and metabolic studies on acetylcysteine","volume":"111","author":"Bonanomi","year":"1980","journal-title":"European Journal of Respiratory Disease"},{"issue":"3-4","key":"10.1002\/14651858.CD007168.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02009054","article-title":"Prevention of tissue damage: inhibition of myeloperoxidase mediated inactivation of alpha 1-proteinase inhibitor by N-acetyl cysteine, glutathione and methionine","volume":"22","author":"Borregaard","year":"1987","journal-title":"Agents Actions"},{"key":"10.1002\/14651858.CD007168.pub2-BIB26|cit26","unstructured":"Cystic Fibrosis Foundation Annual Report CFF Annual Report 2007"},{"issue":"10","key":"10.1002\/14651858.CD007168.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/oxfordjournals.aje.a008664","article-title":"Determinants of mortality from cystic fibrosis in Canada, 1970-1989","volume":"143","author":"Corey","year":"1996","journal-title":"American Journal of Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD007168.pub2-BIB28|cit28","first-page":"73","article-title":"No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid","volume":"70","author":"Cotgreave","year":"1987","journal-title":"European Journal of Respiratory Disease"},{"key":"10.1002\/14651858.CD007168.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/sim.1205","article-title":"Meta-analysis combining parallel and cross-over clinical trials.I: Continuous outcomes","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007168.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/(SICI)1099-0496(199609)22:3<161::AID-PPUL4>3.0.CO;2-S","article-title":"Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with Nacystelyn and rhDNase","volume":"22","author":"Dasgupta","year":"1996","journal-title":"Pediatric Pulmonology"},{"issue":"5","key":"10.1002\/14651858.CD007168.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic Fibrosis since 1938","volume":"173","author":"Davis","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1002\/14651858.CD007168.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.1999.tb01265.x","article-title":"Systematic review of N-acetylcysteine in cystic fibrosis","volume":"88","author":"Duijvestijn","year":"1999","journal-title":"Acta Paediatrica"},{"issue":"1","key":"10.1002\/14651858.CD007168.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD007168.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD007168.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"Follmann","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD007168.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007168.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1165\/rcmb.2003-0345OC","article-title":"MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions","volume":"31","author":"Henke","year":"2004","journal-title":"American journal of respiratory cell and molecular biology"},{"issue":"1","key":"10.1002\/14651858.CD007168.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prrv.2007.02.009","article-title":"Mucolytics in cystic fibrosis","volume":"8","author":"Henke","year":"2007","journal-title":"Paediatric Respiratory Reviews"},{"issue":"7414","key":"10.1002\/14651858.CD007168.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD007168.pub2-BIB40|cit40","article-title":"Recombinant human deoxyribonuclease for cystic fibrosis","author":"Jones","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7303","key":"10.1002\/14651858.CD007168.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"issue":"Suppl 17","key":"10.1002\/14651858.CD007168.pub2-BIB42|cit42","first-page":"438s","article-title":"Determination of the mode of action of a novel mucolytic agent Nacystelyn","volume":"6","author":"Marriott","year":"1993","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD007168.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/ars.2006.8.681","article-title":"Current concepts of redox signaling in the lungs","volume":"8(3-4)","author":"Rahman","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"10.1002\/14651858.CD007168.pub2-BIB44|cit44","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD007168.pub2-BIB45|cit45","first-page":"721","article-title":"The in vitro reduction in viscosity of human tracheobronchial secretions by acetylcysteine","volume":"90","author":"Sheffner","year":"1964","journal-title":"American Review of Respiratory Disease"},{"issue":"5","key":"10.1002\/14651858.CD007168.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.200212-1437OC","article-title":"In Vivo and In Vitro Effects of Macrolide Antibiotics on Mucus Secretion in Airway Epithelial Cells","volume":"168","author":"Shimizu","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"12","key":"10.1002\/14651858.CD007168.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.0511304103","article-title":"High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis","volume":"103","author":"Tirouvanziam","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD007168.pub2-BIB48|cit48","first-page":"77","article-title":"Acetylcysteine","volume-title":"Drugs in Bronchial Mucology","author":"Ventresca","year":"1989"},{"issue":"3","key":"10.1002\/14651858.CD007168.pub2-BIB49|cit49","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001506.pub2","article-title":"Nebulised hypertonic saline for cystic fibrosis","author":"Wark","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007168.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T00:00:00Z","timestamp":1373587200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007168.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T21:19:20Z","timestamp":1684876760000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007168.pub2"}},"subtitle":[],"editor":[{"given":"Edward F","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":49,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007168.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007168.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2009,1,21]]}}}